Clinical trial · Observational
Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization
NCT00586235CI-TRIAL-00038477completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Acquire CT data and US and transducer position data (magnetic sensor system) of focal hepatic or renal lesions to serve as sample data sets for fusion algorithm development and subsequent optimization.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Kidney or Liver Tumors | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- patients with indeterminate kidney or liver lesions
Primary outcomes (1)
- measure
- Primary Endpoints: Global Fiducial Registration Error (FRE) of real-time US and fused CT images, Target Registration Error (TRE) and distance between lesional epicenters of real-time US and fused CT images.
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- Secondary Endpoint: Number of coregistration attempts to realize separation of lesional epicenters of real-time US and fused CT images of ≤2 cm and the number of attempts to realize a separation of ≤0.3 cm.
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Focal lesion involving the liver or kidney bases on CT or MRI Imaging * Liver lesion size \>5 mm and \<5 cm in diameter or renal lesion size is \>5 mm and \<4 cm in diameter * Age \>18 years old * Patient has provided written informed consent Exclusion Criteria: * Patient with cardiac pacemaker or defibrillator * Pregnant or lactating woman * Patient with severe IV contrast allergy (previous reaction to IV contrast not mitigated by appropriate premedication) * Patient unable to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.